SARS-CoV-2 RNA Prevalence in Blood and Serum Samples from UK Clinical Cohort

Supplementary materials for a systematic review and meta-analysis on SARS-CoV-2 RNA prevalence in blood products. The underlying data includes metadata for 28 citations, RT-PCR results from 212 serum samples from a UK clinical cohort and 142 convalescent donor samples, and raw microscope images of cell cultures. The report was authored by Monique Andersson.

Use Cases

• Perform meta-analysis on SARS-CoV-2 RNA prevalence in blood based on systematic review metadata.
• Analyze RT-PCR quantification and viral culture outcomes from patient serum samples.
• Study viral persistence and clearance timelines based on follow-up samples from the same individuals.
• Validate cell culture assays using raw microscope images of Vero E6 cells.

Strengths

• Includes metadata from 28 citations for systematic review.
• Contains underlying data from 212 serum samples from a UK clinical cohort and 142 samples from convalescent donors.
• Provides raw, unedited microscope images for cell culture validation.

Limitations

• Column-level documentation is absent; field semantics must be inferred after download.
• Row count for the main tables is unknown, which may limit suitability assessment.
• Last update date is unknown; freshness unverified.

Provenance

Source

Monique Andersson

Collection Method

Systematic literature review and data collection from a UK clinical cohort (Oxford University Hospitals NHS Foundation Trust) and NHS Blood and Transplant.

Geography

United Kingdom (primary source for serum samples)